A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Urology Oncology Fellowship

Urology Oncology Fellowship
The Division of Urology and Urologic Oncology at City of Hope offers one- and two-year Fellowships in Urologic Oncology/Robotic Surgery with special emphasis on minimally invasive and robotic techniques. The one-year program includes one year of clinical work, while the two-year program includes one year of research and one year of clinical work.  Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena, in addition to their rotation at City of Hope.
 
City of Hope has had a tradition of training future urologic oncologic surgeons since 1992. Approximately 60 percent of our Fellows go on to careers in the academic setting.
 
Contact: Clayton S. Lau, M.D.
Director, Urologic Oncology Fellowship Program
Division of Urology and Urologic Oncology
City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 626-256-4673 ext. 65733
FAX: 626-301-8285
Email: cllau@coh.org


 
A request for additional information may be made to Denise Rasmussen through email drasmussen@coh.org or send to the address above.
 
Eligibility
Candidates must be graduates of an ACGME-accredited urology program. There are currently three to four one-year clinical Fellowship positions available for board eligible/certified urologists. In addition, we have recently expanded the Fellowship and offer two-year Fellowships for those interested in enriching their training in basic science and outcomes research.
The two-year Fellows will spend the first twelve months in a lab working on translational research projects in Urologic Oncology/Robotic Surgery.  The second twelve months will be spent in a clinical Urology service.  During the clinical year, the Fellows participate in over 1,000 laparoscopic/robotic procedures, provide care for in-patients including ICU care, and offer continuity of care in the outpatient clinics.
 
Responsibilities
The Fellow is responsible for all in-patient care and typically operates four days per week with any one of the four current urologic oncology faculty members.  All urologic oncology faculty are Fellowship-trained and members of the Society of Urologic Oncology. The Fellow is currently supported clinically by a nurse practitioner and a physician assistant.
 
Completion of this program also mandates that our Fellows present at national meetings, write research papers, get involved with clinical trials, participate in journal clubs, and present lectures to the oncologic community. Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena in addition to their rotation at City of Hope.
 
Based on current occupancy levels, Fellows would be anticipated to participate in the surgical care and management of approximately 800 laparoscopic robotic radical prostatectomies; 75-80 laparoscopic cystoprostatectomies with urinary diversion; and 100-150 laparoscopic and robotic nephrectomies. A variety of other endoscopic, endourologic and general urology cases occur throughout the year.
 

While minimally invasive techniques are an important part of this program, our Fellows are also trained in complex open surgical techniques, such as post-chemotherapy RPLND’s, nephrectomies, open cystectomies and urinary tract reconstructions.  Because our Fellows train in a nationally recognized NCI-designated cancer center, they also have opportunities to participate in many multi-teamed procedures for abdominal and pelvic malignancies. Fellows are also exposed to a multidisciplinary treatment approach to urologic cancers by developing close relationships with radiation oncology, medical oncology, and uropathology.
 
City of Hope has one-year clinical and two-year research/clinical Fellowships available starting July 2015.  Interviews for these positions have been scheduled for January 2014.
 

Application Process

It is best to begin the application process about a year before your anticipated date of entry into the fellowship.
 
Interested parties should contact:
 
Denise Rasmussen
Fellowship Coordinator
Division of Urology and Urologic Oncology
City of Hope
Email: drasmussen@coh.org
Phone: 626.256.4673 ext. 65733
Fax: 626-301-8285

Please note that before an interview date is scheduled, City of Hope must receive:
 
  • Current curriculum vitae,
  • Two letters of reference from faculty in the candidate’s residency-training program
  • Photo
  • Interviews will take place in January of 2014.
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...